On December 1, 2021, G9pharma co., LTD closed the transaction. The company amended the terms of the transaction and only issued shares in the transaction for gross proceeds of raised KRW 5,999,999,573. The company announced that it has cancelled the issuance of series 14 and series 15 bonds due to failure to pay the full amount of bonds on the payment date by the investor.